Concepedia
Statistics
Publications
4
Citations
58
H-Index
Active since
2022
Affiliations
Lanzhou University(Current)
Hubei University of Medicine
Lanzhou University Second Hospital
Changlong Zhou is an author at Lanzhou University specializing in tumor biology, medicine, and cell biology.
Top concepts
MedicineCell BiologyTumor BiologyCancer BiologyRadiation OncologyCancer Cell BiologyOncologyChromatinLung CancerPharmacology
Publications per year
2022–2023
Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer
Xiaxia Niu, Ting Wu, Qishuang Yin et al. · Cells · 2022 · 18 citations · Full text
Ptx Metabolism, Cancer Biology, Tumor Biology +17
Inhibition of USP14 enhances anti-tumor effect in vemurafenib-resistant melanoma by regulation of Skp2
Ting Wu, Chengyun Li, Changlong Zhou et al. · Cell Biology and Toxicology · 2022 · 16 citations · Full text
Anti-tumor Effect, Medicine, Melanoma +5
Nuclear Receptor PXR Confers Irradiation Resistance by Promoting DNA Damage Response Through Stabilization of ATF3
Xiaxia Niu, Hongmei Cui, Xinsheng Gu et al. · Frontiers in Oncology · 2022 · 14 citations · Full text
Radiation Effect, Radiation Exposure, Molecular Biology +20
MitoCur‐1 induces ferroptosis to reverse vemurafenib resistance in melanoma through inhibition of USP14
Gege Li, Changlong Zhou, Lu Wang et al. · Pigment Cell & Melanoma Research · 2023 · 10 citations · Full text
1–4 of 4